sparfloxacin has been researched along with lactic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ali, A; Aqil, M; Bhatnagar, A; Gupta, H; Khar, RK; Mittal, G | 1 |
| Amar, SK; Chopra, D; Dubey, D; Dwivedi, A; Haldar, C; Kumari, S; Ray, L; Ray, RS; Singh, J; Srivastva, AK; Yadav, RK | 1 |
| Ding, Y; Fan, B; Mao, Z; Wang, W; Wang, Y; Wu, J; Yang, Y | 1 |
4 other study(ies) available for sparfloxacin and lactic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
Topics: Animals; Delayed-Action Preparations; Eye Infections, Bacterial; Fluoroquinolones; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits | 2010 |
PLGA nanoformulation of sparfloxacin enhanced antibacterial activity with photoprotective potential under ambient UV-R exposure.
Topics: Anti-Bacterial Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line; DNA Damage; Drug Carriers; Drug Compounding; Drug Stability; Fluoroquinolones; Humans; Keratinocytes; Lactic Acid; Mitochondria; Molecular Docking Simulation; Molecular Structure; Nanoparticles; Photolysis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Ultraviolet Rays | 2018 |
Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis.
Topics: Animals; Anti-Bacterial Agents; Drug Carriers; Endothelial Cells; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Immunosuppressive Agents; Inflammation; Lactic Acid; Lung; Mice; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sepsis; Tacrolimus | 2020 |